Stepwise circumferential and focal ablation of Barrett’s esophagus with high-grade dysplasia: results of the first prospective series of 11 patients
J. J. Gondrie1
, R. E. Pouw1
, C. M. T. Sondermeijer1
, F. P. Peters1
, W. L. Curvers1
, W. D. Rosmolen1
, K. K. Krishnadath1
, F. Ten Kate2
, P. Fockens1
, J. J. Bergman1
1Department of Gastroenterology, Academic Medical Center, Amsterdam, the Netherlands
2Department of Pathology, Academic Medical Center, Amsterdam, the Netherlands
Background and study aims: Stepwise circumferential and focal ablation of nondysplastic Barrett’s esophagus has proven safe and effective. This study assessed the efficacy and safety of ablation for Barrett’s esophagus with high-grade dysplasia (HGD), and residual Barrett’s esophagus with dysplasia after prior endoscopic resection for visible lesions.
Patients and methods: This was a prospective cohort study. All visible abnormalities were resected prior to ablation. Persistence of dysplasia and absence of invasive cancer was confirmed with biopsies after endoscopic resection. A balloon-based electrode was used for primary circumferential ablation and an endoscope-mounted electrode was used for secondary focal ablation. Eradication of dysplasia and Barrett’s esophagus was the main outcome measure.
Results: Eleven patients (eight men; median age 60 years) were treated (median Barrett’s length 5 cm). Visible abnormalities were removed with endoscopic resection in six patients. The worst pathological grade of residual Barrett’s esophagus after endoscopic resection and prior to ablation was LGD (n = 2) and HGD (n = 9). Patients underwent a median of two circumferential and two focal ablation sessions. Complete remission of dysplasia and complete endoscopic and histological removal of Barrett’s esophagus was achieved in 11/11 patients (100 %). There were no adverse events or strictures, and in none of the 473 biopsies of neo-squamous mucosa was subsquamous Barrett’s esophagus (“buried Barrett’s”) observed. During a median follow-up period of 14 months after the last treatment session and a median number of two follow-up endoscopies, none of the patients showed recurrence of dysplasia or endoscopic signs of recurrent Barrett’s mucosa.
Conclusions: Stepwise circumferential and focal ablation appears to be a safe and effective treatment for complete removal of Barrett’s esophagus containing HGD, and can be safely performed after prior endoscopic resection for endoscopically visible abnormalities.
References
1
Peters F P, Kara M A, Rosmolen W D. et al .
Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus.
Gastrointest Endosc.
2005;
61
506-514
2
Peters F P, Kara M A, Rosmolen W D. et al .
Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: a prospective study.
Am J Gastroenterol.
2006;
101
1449-1457
3
Pech O, Gossner L, May A. et al .
Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia.
Gastrointest Endosc.
2005;
62
24-30
4
Overholt B F, Lightdale C J, Wang K K. et al .
Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial.
Gastrointest Endosc.
2005;
62
488-498
5
Ell C, May A, Pech O. et al .
Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer).
Gastrointest Endosc.
2007;
65
3-10
6
Prasad G A, Wang K K, Buttar N S. et al .
Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus.
Gastroenterology.
2007;
132
1226-1233
7
May A, Gossner L, Pech O. et al .
Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach.
Eur J Gastroenterol Hepatol.
2002;
14
1085-1091
8
Bergman J J.
Endoscopic treatment of high-grade intraepithelial neoplasia and early cancer in Barrett's oesophagus.
Best Pract Res Clin Gastroenterol.
2005;
19
889-907
10
Seewald S, Akaraviputh T, Seitz U. et al .
Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma.
Gastrointest Endosc.
2003;
57
854-859
11
Peters F P, Krishnadath K K, Rygiel A M. et al .
Stepwise radical endoscopic resection of the complete Barrett's esophagus with early neoplasia successfully eradicates pre-existing genetic abnormalities.
Am J Gastroenterol.
2007;
102
1853-1861
12
Ackroyd R, Brown N J, Davis M F. et al .
Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial.
Gut.
2000;
47
612-617
13
Peters F, Kara M, Rosmolen W. et al .
Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection.
Endoscopy.
2005;
37
418-424
14
Ackroyd R, Tam W, Schoeman M. et al .
Prospective randomized controlled trial of argon plasma coagulation ablation vs. endoscopic surveillance of patients with Barrett's esophagus after antireflux surgery.
Gastrointest Endosc.
2004;
59
1-7
15
Dulai G S, Jensen D M, Cortina G. et al .
Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus.
Gastrointest Endosc.
2005;
61
232-240
16
Overholt B F, Panjehpour M, Halberg D L.
Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results.
Gastrointest Endosc.
2003;
58
183-188
17
Hornick J L, Blount P L, Sanchez C A. et al .
Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett's esophagus.
Am J Surg Pathol.
2005;
29
372-380
18
Van Laethem J L, Peny M O, Salmon I. et al .
Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus.
Gut.
2000;
46
574-577
19
Hage M, Siersema P D, Vissers K J. et al .
Genomic analysis of Barrett's esophagus after ablative therapy: persistence of genetic alterations at tumor suppressor loci.
Int J Cancer.
2006;
118
155-160
20
Krishnadath K K, Wang K K, Taniguchi K. et al .
Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy.
Gastroenterology.
2000;
119
624-630
21
Ragunath K, Krasner N, Raman V S. et al .
Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness.
Scand J Gastroenterol.
2005;
40
750-758
22
Sharma V K, Wang K K, Overholt B F. et al .
Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients.
Gastrointest Endosc.
2007;
65
185-195
24
Sharma P, Dent J, Armstrong D. et al .
The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria.
Gastroenterology.
2006;
131
1392-1399
26
Peters F P, Kara M A, Curvers W L. et al .
Multiband mucosectomy for endoscopic resection of Barrett's esophagus: feasibility study with matched historical controls.
Eur J Gastroenterol Hepatol.
2007;
19
311-315
27
Dunkin B J, Martinez J, Bejarano P A. et al .
Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device.
Surg Endosc.
2006;
20
125-130
28
Ganz R A, Utley D S, Stern R A. et al .
Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus.
Gastrointest Endosc.
2004;
60
1002-1010
29
Morales T G, Camargo E, Bhattacharyya A. et al .
Long-term follow-up of intestinal metaplasia of the gastric cardia.
Am J Gastroenterol.
2000;
95
1677-1680